Circulation 146(24):18821894 Mary P, Curtis R (2010) Weighing risks and benefits of liraglutide the FDAs review of a new antidiabetic therapy
If you are considering Ozempic, Wegovy, Mounjaro, or similar medications, speak with your healthcare provider to determine whether they are appropriate for your kidney health needs
Bhullar KS, Lagaron NO, McGowan EM, Parmar I, Jha A, Hubbard BP, et al
16: One of the most-anticipated FDA decisions of the first half of 2024 came early as the regulator approved Vertex Pharmaceuticals and CRISPR Therapeutics Casgevy (exagamglogene autotemcel) as a one-time treatment for transfusion-dependent beta-thalassemia (TDT)
Because they're also rich in the antioxidant quercetin, another compound proven to increase GLP-1 secretion